The Acute Myeloid Leukemia (AML) market is witnessing a transformative phase driven by innovative therapies and expanding treatment modalities. Increasing patient populations alongside advancements in targeted therapeutics are shaping substantial business growth opportunities in this critical oncology segment. Industry trends reflect a growing focus on personalized medicine and combination...